EPHA5, His, Mouse
EPHA5, His, Mouse

The purity of EPHA5, His, Mouse is greater than 95% as determined by SEC-HPLC.

EPHA5, His, Mouse

EPHA5, His, Mouse on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

EPHA5, His, Mouse

The aim of the present study was to evaluate ephrin type-A receptor 5 (EphA5) expression and its clinicopathological significance in gastric cancer. Gastric cancer tissues were analyzed by immunohistochemistry. The association between EphA5 expression and clinicopathological parameters, human epidermal growth factor receptor 2 (HER2) status and Ki-67 proliferation index was statistically analyzed.
Z06103
¥72,752.00

Ask us a question
Product Introduction
Species Mouse
Protein Construction
EPHA5 (Pro27-Pro412)_x000D_
Accession # Q60629		 His
N-term C-term
Purity > 95% as determined by Bis­Tris PAGE 
> 95% as determined by HPLC
Endotoxin Level Less than 1EU per μg by the LAL method.
Expression System HEK293
Theoretical Molecular Weight 43.9 kDa
Apparent Molecular Weight Due to glycosylation, the protein migrates to 48-55 kDa based on Bis-Tris PAGE result.
Formulation Lyophilized from 0.22μm filtered solution in PBS (pH 7.4).
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage & Stability Upon receiving, the product remains stable up to 6 months at -20 °C or below. Upon reconstitution, the product should be stable for 3 months at -80 °C. Avoid repeated freeze-thaw cycles.

Examples
  • EPHA5, His, Mouse
    • EPHA5, His, Mouse

    The purity of EPHA5, His, Mouse is greater than 95% as determined by SEC-HPLC.

  • EPHA5, His, Mouse
    • EPHA5, His, Mouse

    EPHA5, His, Mouse on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.


Background
Target Background The aim of the present study was to evaluate ephrin type-A receptor 5 (EphA5) expression and its clinicopathological significance in gastric cancer. Gastric cancer tissues were analyzed by immunohistochemistry. The association between EphA5 expression and clinicopathological parameters, human epidermal growth factor receptor 2 (HER2) status and Ki-67 proliferation index was statistically analyzed.
Synonyms EHK-1; EK7; BSK; EHK1; HEK7; TYRO4; EphA5; Rek7; TYRO4HEK7CEK7

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.